The research found that injection of an engineered hydrogel made up mainly of hyaluronic acid into the spinal cord injury site decreases scarring and promotes a realignment of the spinal cord fibers around the injury site.
Low back pain is common in the United States, resulting in substantial disability and cost to society. How is low back pain treated? Researchers found that yoga are more likely to reduce chronic low back pain in minority populations.
The experimental compound, 4-aminopyridine-3-methyl hydroxide, has been shown to restore function to damaged axons, slender fibers that extend from nerve cells and transmit electrical impulses in the spinal cord.
Study confirms that cannabis is beneficial for multiple sclerosis. Cannabis can reduce spasticity in multiple sclerosis (MS) patients.
What is epilepsy? Epilepsy is a chronic (long-lasting) medical condition marked by recurrent epileptic seizures. An epileptic seizure is an event of altered brain function caused by abnormal or excessive electrical discharges from brain cells.
UV LED therapy shows promising results in preventing focal Epilepsy. Researchers from the University of Minnesota Medical School discovered that light from an ultraviolet diode (UV LED) reduced “seizure-like” activity in a rat epilepsy model.
A clinical trial of a new neuroprotective drug for people with traumatic brain injuries will be offered to patients seen in UC Davis Medical Center’s level-1 trauma center. The study’s primary aim is to determine whether the drug, a neuroactive steroid called allopregnanolone, would be an effective treatment for severe brain injuries.
Optometric vision therapy helps children with math problems. Math ability is essential for many occupations and professions.
Some older patients with acute myeloid leukemia (AML) could benefit from a drug that modifies gene activity that cancer cells turn off, according to research at Washington University School of Medicine in St. Louis and collaborating institutions.
Johns Hopkins Kimmel Cancer Center researchers say a vaccine appears to ‘Mop Up’ the last remaining cancer cells in some chronic myeloid leukemia (CML) patients taking the drug Imatinib mesylate (Gleevec).